Clinical Trials Directory

Trials / Unknown

UnknownNCT02771756

The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy

Randomized, Self Controlled Study on the Effect of Oral Supplement of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Chinese Academy of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to research more reasonable and safe methods of nutritional support to improve the nutritional status of tumor patients, which guarantees the anti-tumor treatment such as chemotherapy.

Detailed description

This study is a prospective, randomized, controlled clinical trials. 300 patients were randomly divided into 2 groups for its own control study. Test group: Zhen qishen capsule (2 capsules, Bid) and Oral Supplement of Yuyikang (50g,Bid), a total of 150 people, are used for 42 days continuously. Placebo group: Zhen qishen capsule placebo (2 capsules, Bid) and Oral Supplement of Yuyikang placebo (50g, Bid), a total of 150 people, are used for 42 days continuously. The subjects were randomized to AB or BA parallely, and the two groups were given chemotherapy and nutrition.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTzhen qishen capsule and Oral Supplement of Yuyikang
DIETARY_SUPPLEMENTzhen qishen capsule placebo and Oral Supplement of Yuyikang placebo
RADIATIONchemotherapy
OTHERnutrition education

Timeline

Start date
2015-05-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2016-05-13
Last updated
2016-05-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02771756. Inclusion in this directory is not an endorsement.